Product Images Oxcarbazepine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Oxcarbazepine NDC 70518-1055 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
OXcarbazepine 300mg 70518 1055 00
This is a prescription medicine called Oxcarbazepine, packaged in a bottle containing 30 tablets of 300mg each. The NDC number is 70518-1055-00; the LOT # and expiration date are not specified. The medicine was manufactured by Sun Pharma in Cranbury, NJ. The directions for use are found in the package insert, and the medicine should be stored at 20-25°C (88-77°F). It can be kept between 15-30°C (59-86°F) temporarily. The medicine was repackaged by RemedyRepack Inc. in Indiana, PA.*
chemical-structure - chemical structure
figure 1 - figure1
The text is a statistical figure showing Kaplan-Meier estimates of Exit Rate by Treatment Group. The figure denotes the exit rate on day 11 and estimates the treatment group's efficacy by comparing the oxcarbazepine and placebo groups. A log-rank test was conducted, and the p-value found to be 0.0001, showing a significant difference between the treatment groups.*
figure-2 - figure2
The text provides a figure (Figure 2) showing a graph of Kaplan-Meier estimates of first seizure event rate by treatment group. The graph displays a log-rank test result with a p-value of 0.046. There is also a horizontal axis indicating "days from 1st dose to 1st seizure" and a vertical axis with "seizure rate" values. The two treatment groups compared are Oxcarbazepine and Placebo.*
figure-3 - figure3
The figure shows the Kaplan-Meier estimates of the exit rate by treatment group. The exit rate is measured on the y-axis while the time to exit (in days) is on the x-axis. The treatment group is categorized into HIGH and LOW, with a log-rank test p-value of 0.0001. No other information is given.*
figure-4 - figure4
The text provides a plot and a statistical analysis of the Exit Rate by Treatment Group using the Kaplan-Meier estimates. The analysis includes a p-value obtained from a log-rank test. The plot displays the time to exit in days versus the treatment group. However, the last line of text is not legible, possibly due to errors.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.